Sign In
Buy CERC
$0.319
+0.0060 (+1.92%)
At Close: May 27, 2022
Cerecor Inc. Announces Closing of $36.4 Million Public Offering of Common Stock and Pre-Funded Warrants
04:01pm, Tuesday, 12'th Jan 2021
ROCKVILLE, Md. and CHESTERBROOK, Pa., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Cerecor Inc. (Nasdaq: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of tr
Cerecor Inc. Announces Pricing of $36.4 Million Public Offering of Common Stock and Pre-Funded Warrants
10:03pm, Thursday, 07'th Jan 2021
ROCKVILLE, Md. and CHESTERBROOK, Pa., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Cerecor Inc. (Nasdaq: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of tr
Cerecor Inc. Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
04:01pm, Thursday, 07'th Jan 2021
ROCKVILLE, Md. and CHESTERBROOK, Pa., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Cerecor Inc. (Nasdaq: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of tr
Cerecor Announces FDA Acceptance of Investigational New Drug Application for CERC-007 for the Treatment of Still's Disease
01:00pm, Tuesday, 22'nd Dec 2020
ROCKVILLE, Md. and CHESTERBROOK, Pa., Dec. 22, 2020 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of tr
Cerecor Announces First Patient Dosed in a Phase 1b Clinical Trial of CERC-007 for the Treatment of Relapsed or Refractory Multiple Myeloma
07:00am, Wednesday, 16'th Dec 2020
Initial data anticipated in the first quarter of 2021 Initial data anticipated in the first quarter of 2021
Cerecor Announces FDA Acceptance of Investigational New Drug Application for CERC-803 to Treat Leukocyte Adhesion Deficiency Type II
07:00am, Tuesday, 01'st Dec 2020
ROCKVILLE, Md. and CHESTERBROOK, Pa., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of tr
Cerecor to Collaborate with Frontiers CDG Consortium on Pivotal Trial of CERC-801 for the Treatment of PGM1-CDG
07:00am, Tuesday, 17'th Nov 2020
ROCKVILLE, Md., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in the development and commercialization of treatments for rare
Cerecor Reports Third Quarter 2020 Financial Results and Provides Business Update
04:01pm, Monday, 09'th Nov 2020
On track to complete clinical trial for CERC-002 in cytokine storm-induced COVID-19 ARDS by year end
4 Health Stocks Stonepine Capital Loves (1 Has Gained 233% Since September 29)
08:09am, Monday, 26'th Oct 2020
Timothy P. Lynch's Stonepine Capital is a life science-focused hedge fund that seeks to utilize its industry experience to uncover undervalued and under-the-radar health companies. The fund takes a lo
Wither independent electricity regulation?
05:45am, Tuesday, 20'th Oct 2020
The apex court’s direction to appoint a member (Law) at the CERC is an opportunity to revive independent regulation. To that end, the CERC must have full autonomy and accountability, apart from bein
12 Healthcare Stocks Moving In Tuesday's After-Market Session
12:00am, Tuesday, 06'th Oct 2020
Gainers
Integra Lifesciences (NASDAQ:IART) stock surged 6.33% to $51.9 during Tuesday's after-market session. This security traded at a volume of 11.8K shares come close,...
Jane Street Group LLC Buys New Stake in Cerecor Inc (NASDAQ:CERC)
06:18am, Sunday, 04'th Oct 2020
Jane Street Group LLC bought a new stake in shares of Cerecor Inc (NASDAQ:CERC) during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 14,050 shar
What is a power market coupler and does India really need it?
07:55am, Monday, 07'th Sep 2020
If the market coupler becomes a reality, there will be no incentive left for the power exchanges to innovate since the coupler would centralise the platform
Cerecor (CERC) Presents At Wedbush Pacgrow Healthcare Virtual Conference - Slideshow
06:04pm, Thursday, 13'th Aug 2020
The following slide deck was published by Cerecor Inc. in conjunction with this event..
CERC: Topline Data from COVID ARDS Trial in 4Q20…
01:00pm, Thursday, 13'th Aug 2020
By David Bautz, PhD NASDAQ:CERC READ THE FULL CERC RESEARCH REPORT Business Update Proof-of-Concept Data for CERC-002 in ARDS in 4Q20 Cerecor, Inc. (NASDAQ:CERC) is currently conducting a proof-of-con
